BG29281A3 - Method of obtaining of 1- (p- methoxybenzoil)- 2- pirolidinon - Google Patents

Method of obtaining of 1- (p- methoxybenzoil)- 2- pirolidinon

Info

Publication number
BG29281A3
BG29281A3 BG042414A BG4241479A BG29281A3 BG 29281 A3 BG29281 A3 BG 29281A3 BG 042414 A BG042414 A BG 042414A BG 4241479 A BG4241479 A BG 4241479A BG 29281 A3 BG29281 A3 BG 29281A3
Authority
BG
Bulgaria
Prior art keywords
pirolidinon
methoxybenzoil
obtaining
methoxybenzoyl
pyrrolidinone
Prior art date
Application number
BG042414A
Other languages
Bulgarian (bg)
English (en)
Inventor
Emilio Kyburz
Werner Aschwanden
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of BG29281A3 publication Critical patent/BG29281A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
BG042414A 1978-02-10 1979-02-08 Method of obtaining of 1- (p- methoxybenzoil)- 2- pirolidinon BG29281A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140378 1978-02-10
CH1198178 1978-11-22

Publications (1)

Publication Number Publication Date
BG29281A3 true BG29281A3 (en) 1980-10-15

Family

ID=25687541

Family Applications (1)

Application Number Title Priority Date Filing Date
BG042414A BG29281A3 (en) 1978-02-10 1979-02-08 Method of obtaining of 1- (p- methoxybenzoil)- 2- pirolidinon

Country Status (34)

Country Link
US (1) US4369139A (fr)
EP (2) EP0005143B1 (fr)
JP (1) JPS6059907B2 (fr)
AR (1) AR220739A1 (fr)
AT (1) AT374787B (fr)
AU (1) AU525514B2 (fr)
BG (1) BG29281A3 (fr)
BR (1) BR7900684A (fr)
CA (1) CA1100515A (fr)
CS (1) CS226182B2 (fr)
CU (1) CU21107A3 (fr)
DD (1) DD141828A5 (fr)
DE (1) DE2963321D1 (fr)
DK (1) DK155278C (fr)
EG (1) EG13873A (fr)
ES (2) ES477587A1 (fr)
FI (1) FI69063C (fr)
GR (1) GR71464B (fr)
HK (1) HK6185A (fr)
HU (1) HU177644B (fr)
IE (1) IE47831B1 (fr)
IL (1) IL56587A0 (fr)
IN (1) IN150106B (fr)
MC (1) MC1257A1 (fr)
MY (1) MY8500340A (fr)
NO (1) NO152046C (fr)
NZ (1) NZ189571A (fr)
OA (1) OA06180A (fr)
PH (1) PH15491A (fr)
PL (1) PL115958B1 (fr)
PT (1) PT69206A (fr)
RO (1) RO76615A (fr)
SU (1) SU931104A3 (fr)
YU (1) YU41330B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8004025A (nl) * 1979-08-09 1981-02-11 Hoffmann La Roche Pyrrolidinederivaten en werkwijze voor het bereiden daarvan alsmede geneesmiddel.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4398938A (en) * 1982-05-20 1983-08-16 Velsicol Chemical Corporation N-Acylated lactams and their herbicidal compositions and method of use
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
CH661174GA3 (fr) * 1985-07-10 1987-07-15
US4691853A (en) * 1985-12-30 1987-09-08 Technalytics, Inc. Surgical stapler
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5300642A (en) * 1986-04-10 1994-04-05 The Du Pont Merck Pharmaceutical Company α, α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (fr) * 1987-08-19 1992-07-14 Hiromu Matsumura Derives de carbamoylpyrrolidone et produits pharmaceutiques pour la demence senile
JP2585086B2 (ja) * 1988-12-28 1997-02-26 大鵬薬品工業株式会社 ジアザビシクロアルカン誘導体
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
JP2803882B2 (ja) * 1990-02-20 1998-09-24 日清製粉株式会社 １―フエノキシカルボニル―２―ピロリジノン誘導体
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
DK1156043T3 (da) * 1992-07-24 2004-03-01 Univ California Lægemidler, der forøger synaptiske reaktioner formidlet af ampa-receptorer
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
ATE198472T1 (de) * 1995-02-21 2001-01-15 Nippon Suisan Kaisha Ltd Gluteminsäurerezeptor agonisten
IT1318490B1 (it) * 1999-04-27 2003-08-25 Hoffmann La Roche Agente per fare aumentare la cessione di acetilcolina cerebrale.
US7608636B2 (en) 2000-12-28 2009-10-27 Hamilton Pharmaceuticals, Inc. Medicines for treatment and prevention of neurogenic pain
US8858594B2 (en) * 2008-12-22 2014-10-14 Abbott Laboratories Curved closure device
EP2604592B1 (fr) 2011-12-12 2014-10-08 Zaklady Farmaceutyczne Polpharma SA Procédé de purification d'aniracetam par cristallisation de solutions aqueuses
CN109651222A (zh) * 2018-12-21 2019-04-19 上海昊航化工有限公司 一种阿尼西坦的催化合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697563A (en) * 1970-06-29 1972-10-10 Inst Chemioterapico Italiano S (3,4,5-trimethoxy-benzamido)-alkanoic acids for prophylaxis and treatment of cardiac disorders
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
ES433723A1 (es) * 1975-01-10 1976-11-16 Lafarquim S A Lab Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.

Also Published As

Publication number Publication date
EP0044088A3 (en) 1982-02-03
IN150106B (fr) 1982-07-24
PL115958B1 (en) 1981-05-30
GR71464B (fr) 1983-05-30
US4369139A (en) 1983-01-18
EP0005143A1 (fr) 1979-11-14
RO76615A (fr) 1981-04-30
DD141828A5 (de) 1980-05-21
NZ189571A (en) 1984-07-06
SU931104A3 (ru) 1982-05-23
CU21107A3 (es) 1988-02-01
PT69206A (en) 1979-03-01
MY8500340A (en) 1985-12-31
AR220739A1 (es) 1980-11-28
AU4391679A (en) 1979-08-16
EP0044088A2 (fr) 1982-01-20
CS226182B2 (en) 1984-03-19
CA1100515A (fr) 1981-05-05
JPS6059907B2 (ja) 1985-12-27
ES477587A1 (es) 1980-01-16
AT374787B (de) 1984-05-25
DK56379A (da) 1979-08-11
HU177644B (en) 1981-11-28
DK155278B (da) 1989-03-20
IE47831B1 (en) 1984-06-27
BR7900684A (pt) 1979-09-04
ATA99579A (de) 1983-10-15
NO152046B (no) 1985-04-15
OA06180A (fr) 1981-06-30
FI790226A (fi) 1979-08-11
PH15491A (en) 1983-01-31
ES483756A1 (es) 1980-04-16
DE2963321D1 (en) 1982-09-02
PL213340A1 (fr) 1980-03-24
NO152046C (no) 1985-07-24
YU28379A (en) 1983-02-28
DK155278C (da) 1989-07-24
MC1257A1 (fr) 1980-01-14
JPS54117468A (en) 1979-09-12
NO790434L (no) 1979-08-13
AU525514B2 (en) 1982-11-11
IL56587A0 (en) 1979-05-31
YU41330B (en) 1987-02-28
EP0044088B1 (fr) 1984-02-22
FI69063C (fi) 1985-12-10
IE790246L (en) 1979-08-20
EG13873A (en) 1982-12-31
FI69063B (fi) 1985-08-30
EP0005143B1 (fr) 1982-07-14
HK6185A (en) 1985-02-01

Similar Documents

Publication Publication Date Title
BG29281A3 (en) Method of obtaining of 1- (p- methoxybenzoil)- 2- pirolidinon
BG28708A3 (en) Method of obtaining of imidazole derivatives
BG31496A3 (en) Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid
BG37075A3 (en) Method for preparing derivatives of proline
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
BG32851A3 (en) Method for obtaining of 3, 4, 5, 6- tetrahydro- 2 h- 1- benzoxycin
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG34908A3 (en) Method for preparing d- 6- n- propylergolines
BG35330A3 (en) Method for preparing 3- iodine- methylcephalosporines
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG41822A3 (en) Method for preparing pyridyl derivatives
BG41126A3 (en) Method for preparing benzamides
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG28849A3 (en) Method of obtaining of gamapyrons
BG32853A3 (en) Method for obtaining of 1- oxadethiacephalosporine
BG35746A3 (en) Method for preparing 1- cyclohexenylmethylpyrolidines
BG33292A3 (en) Method for obtaining of penamsulphooxide derivatives
BG35897A3 (en) Method for preparing 5- (dihydroxy- phenoxy)- 1h- tetrazoles
BG35045A3 (en) Method for preparing substituted triarylthiazolic compounds
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG35896A3 (en) Method for preparing 3- halogen- 3- cephem compounds
BG35895A3 (en) Method for preparing of n- substituted- 2- haloacetanilides
BG30918A3 (en) Method for obtaining of substituated 5h- dibenz ( b, f )- azerine
BG36347A3 (en) Method for preparing thienopyridinon derivatives
BG36633A3 (en) Method for preparing 3- hydroxycephalosporines